EVGN (EVGN) Stock Price & Analysis
EVGN (EVGN) fell 0.04% to USD 0.54 as of July 25, 2026 at 07:27 UTC, according to Nexqual real-time market data.
EVGN last closed at USD 0.54; the session ranged USD 0.53–0.56 on volume of 30,017 shares. Market capitalization is $6.57M, with a 52-week range of USD 0.37–1.5 (NCM). Source: Nexqual, July 25, 2026 at 07:27 UTC.
Key Statistics (as of July 25, 2026 at 07:27 UTC)
| Price | USD 0.54 |
|---|---|
| Change | ▼ 0.04% (down) |
| Previous Close | USD 0.54 |
| Open | USD 0.56 |
| Day Range | USD 0.53 – 0.56 |
| 52-Week Range | USD 0.37 – 1.5 |
| Volume | 30,017 shares |
| Market Cap | $6.57M |
| Exchange | NCM |
Technical Analysis (EVGN)
Nexqual's technical model rates EVGN "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 07:27 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.39 (neutral) |
| vs SMA50 | Below (USD 0.57) |
| MACD | 0 (positive) |
Analyst Ratings (EVGN)
Wall Street analysts rate EVGN "None" based on 1 analysts, with a mean price target of USD 2.15 (range USD 2.15–2.15), per Nexqual as of July 25, 2026 at 07:27 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 2.15 |
| High Target | USD 2.15 |
| Low Target | USD 2.15 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (EVGN)
| Next Earnings Date | 2026-08-20 |
|---|---|
| EPS Estimate | USD -0.27 |
| Revenue Estimate | $325,000 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.61 vs est -0.27 ▼ miss |
| 2025-12-31 | USD -0.62 vs est -0.26 ▼ miss |
| 2025-09-30 | USD -0.46 vs est -0.41 ▼ miss |
| 2025-06-30 | USD -0.5 vs est -0.63 ▲ beat |
Source: Nexqual, July 25, 2026 at 07:27 UTC.
Financials & Fundamentals (EVGN)
| Total Revenue | $1.84M |
|---|---|
| Revenue Growth (YoY) | -86.30% |
| Gross Margin | -46.80% |
| Operating Margin | -952.10% |
| Profit Margin | +0.00% |
| ROE | -171.75% |
| Debt / Equity | 25.42 |
| Current Ratio | 2.79 |
| Total Cash | $13.05M |
| Total Debt | $2.03M |
| Free Cash Flow | $-12.20M |
Source: Nexqual, July 25, 2026 at 07:27 UTC.
Financial Health Score (EVGN)
Nexqual rates EVGN's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 07:27 UTC.
| Growth | Critical — Revenue -55% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $13M cash vs $2M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$12M, burning cash |
| Efficiency | Critical — ROE -172%, ROA -32.9% |
Ownership (EVGN)
| Insider Ownership | +17.02% |
|---|---|
| Institutional Ownership | +4.01% |
| Shares Outstanding | 12.10M |
| Float | 10.33M |
| Short % of Float | +2.07% |
Source: Nexqual, July 25, 2026 at 07:27 UTC.
Leadership (EVGN)
EVGN is led by Ofer Haviv (age 59), CEO, President & Director, per Nexqual as of July 25, 2026 at 07:27 UTC.
| CEO, President & Director | Ofer Haviv (age 59) |
|---|---|
| Chief Financial Officer | Polina Ravzin (age 43) |
| Chief Technology Officer | Ilia Zhidkov (age 48) |
| Vice President of Human Resources | Liat Foigel Wejgman |
Major Backers & Investors (EVGN)
Notable institutional backers of EVGN include SilverArc Capital Management, LLC, according to Nexqual as of July 25, 2026 at 07:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| SilverArc Capital Management, LLC | 0.61% |
Source: Nexqual, July 25, 2026 at 07:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AQB | AquaBounty Technologies, Inc. | USD 0.91 | ▼ 3.7% |
| CGEN | Compugen Ltd. | USD 2.28 | ▼ 5.79% |
| FRSX | Foresight Autonomous Holdings L | USD 1.35 | ▼ 5.45% |
| KMDA | Kamada Ltd. | USD 7.06 | ▲ 0.71% |
| ENLV | Enlivex Ltd. | USD 4.2 | ▼ 8.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 07:27 UTC. This page is informational and not investment advice.